MAPT and Mental deterioration: Instead, biomarker discordance carried prognostic relevance as a marker of progression toward established amyloid-β pathology, thus allowing identification of individuals at subsequent risk of clinical progression, cognitive decline, increased neurodegeneration, and tau pathology.